Phase 2 Study of EC145 Alone Versus EC145+Docetaxel Versus Docetaxel Alone in Participants With FR(++) 2nd Line Non Small Cell Lung Cancer
Clinical trial NCT01577654 · COMPLETED
Trial details
- NCT number
- NCT01577654
- Sponsor
- Endocyte
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-03-01
- Primary completion
- 2013-12-01
- Enrollment
- 203
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.